Clinical Trials Directory

Trials / Completed

CompletedNCT01317940

Nutrition and Body Composition in Acute Lymphoblastic Leukemia

Nutrition and Body Composition in Acute Lymphoblastic Leukemia (Environment and Microenvironment in ALL #2)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Children's Hospital Los Angeles · Academic / Other
Sex
All
Age
10 Years – 29 Years
Healthy volunteers
Accepted

Summary

Many adolescents with acute lymphoblastic leukemia (ALL) have been found to have low bone density by the end of treatment. This can lead to long-term suffering in survivors due to poor bone health. Vitamin D is known to be associated with bone health and previous research has established that Vitamin D insufficiency is very common at diagnosis of ALL and worsens over the course of treatment. Researchers have also learned that a relationship exists between both Vitamin D and fat tissue and ALL and fat tissue. In adolescents being treated for ALL as well as in early survivors, this randomized study will therefore examine the effect of Vitamin D and calcium supplementation on correcting Vitamin D insufficiency and on improving bone density in the context of changes in body composition and body fat. Bone density will be measured by a radiology exam called qCT (quantitative computed tomography) while body composition and body fat will be measured by a different radiology exam called a DXA (dual energy x-ray absorptiometry scan) . The study will also examine in depth the relationship between these three elements - Vitamin D insufficiency, obesity, and ALL - and their impact on bone density.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D and Calcium CitrateVitamin D (10,000 int.units/ml) 100,000 int. units (10ml) by mouth once every two months x 3 times (total treatment period approximately 6-7 months) Calcium Carbonate (1,000 mg/tab = 400 mg elemental calcium/tab) 2,000 mg (2 chewable tabs) by mouth every day for approximately 6-7 months

Timeline

Start date
2011-03-01
Primary completion
2014-12-01
Completion
2016-01-01
First posted
2011-03-18
Last updated
2020-07-08
Results posted
2020-07-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01317940. Inclusion in this directory is not an endorsement.